Carlsmed receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Carlsmed Inc (CARL)
Assess today's live Carlsmed Inc (CARL) share price, performance and insights using our live NASDAQ: CARL stock exchange data.
Analyse the historical data and Carlsmed Inc share price performance charts on this page. Our technical summary section provides analysis on Carlsmed share price buy/sell indicators using real-time data (or discuss the Carlsmed (CARL) stock price today with other investors in the Carlsmed NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ CARL share price (ISIN: US14280C1053) to enhance your trading decisions with our free investment tools and resources.
What Is the Carlsmed Inc Share Price Today?
The Carlsmed share price today is 10.75.
What Is the Stock Symbol for Carlsmed Inc
The stock symbol (or 'ticker') for Carlsmed Inc is "CARL."
What Stock Exchange Does Carlsmed Inc Trade On?
Carlsmed Inc is listed and trades on the NASDAQ stock exchange.
Is Carlsmed Inc a Good Stock to Buy?
Determining whether Carlsmed Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and Carlsmed Inc share price performance charts on this page. Our technical summary section provides analysis on Carlsmed share price buy/sell indicators using real-time data (or discuss the Carlsmed (CARL) stock price today with other investors in the Carlsmed NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ CARL share price (ISIN: US14280C1053) to enhance your trading decisions with our free investment tools and resources.
What Is the Carlsmed Inc Share Price Today?
The Carlsmed share price today is 10.75.
What Is the Stock Symbol for Carlsmed Inc
The stock symbol (or 'ticker') for Carlsmed Inc is "CARL."
What Stock Exchange Does Carlsmed Inc Trade On?
Carlsmed Inc is listed and trades on the NASDAQ stock exchange.
Is Carlsmed Inc a Good Stock to Buy?
Determining whether Carlsmed Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
NASDAQ
Currency in USD
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
10.73
11.27
52 wk Range
8.50
17.19
Earnings results expected in 14 days
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
10.7311.27
52 wk Range
8.5017.19
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
CARL Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Analysts Sentiment
Strong Buy
Price Target
18.60
Upside
+73.02%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Net income is expected to drop this year
- Carlsmed reports 61% revenue growth in Q4 2025
- Investing.com
- Carlsmed receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Carlsmed receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- Carlsmed receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Carlsmed receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Carlsmed receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Strong Sell
Moving Averages
Neutral
Carlsmed, Inc., a commercial-stage medical technology company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures. Its aprevo platform includes proprietary surgical planning software, using outcomes-based algorithms that are aided with artificial intelligence, and resulting custom-built, anatomically designed vertebral interbody implants. The company was incorporated in 2018 and is based in Carlsbad, California.
Carlsmed Inc Earnings Call Summary for Q4/2025
- Carlsmed reported 86% YoY revenue growth to $50.5M in 2025, with gross margin improving to 75.3% from 73.8% in 2024.
- Operating expenses surged 55% to $68.6M, widening GAAP net loss to $29.6M from $24.3M; adjusted EBITDA negative $28.4M.
- Company completed July 2025 IPO raising $100M+; stock fell 3.83% aftermarket to $13.06 despite strong revenue performance.
- Management projects 2026 revenue of $70.17M with mid-70s gross margins, citing path to profitability through operational leverage.
- Analysts set price targets of $17-$24, though rising expenses and widened losses present near-term profitability challenges.
Last Updated: 25/02/2026, 22:30
Read Full TranscriptCompare CARL to Peers and Sector
Metrics to compare | CARL | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipCARLPeersSector | |
|---|---|---|---|---|
P/E Ratio | −9.5x | −6.3x | −0.5x | |
PEG Ratio | −0.15 | −0.16 | 0.00 | |
Price/Book | 2.9x | 4.0x | 2.6x | |
Price / LTM Sales | 5.7x | 3.3x | 3.2x | |
Upside (Analyst Target) | 64.5% | 53.2% | 44.7% | |
Fair Value Upside | Unlock | 15.9% | 5.7% | Unlock |
Analyst Ratings
5 Buy
0 Hold
0 Sell
Ratings:
5 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 18.60
(+73.02% Upside)
Earnings
Latest Release
25/02/2026
EPS / Forecast
-0.32 / -0.35
Revenue / Forecast
15.2M / 14.9M
People Also Watch
FAQ
What Is the Carlsmed (CARL) Share Price Today?
The Carlsmed stock price today is 10.75 USD.
What Stock Exchange Does Carlsmed (CARL) Trade On?
Carlsmed is listed and trades on the Nasdaq Stock Exchange.
What Is the Ticker (Stock Symbol) for Carlsmed?
The stock symbol (also called a 'ticker') for Carlsmed is "CARL."
What Is the Current Carlsmed Market Cap?
As of today, Carlsmed market cap is 292.45M USD.
What Is Carlsmed's (CARL) Earnings Per Share (TTM)?
The Carlsmed EPS is currently -2.12 (Trailing Twelve Months).
When Is the Next Carlsmed Earnings Date?
Carlsmed's next earnings report will be released on 05/05/2026.
Is CARL a Buy or Sell From a Technical Analyst Perspective?
Based on today's Carlsmed moving averages and other technical indicators, the daily buy/sell signal is Neutral.
How Many Times Has Carlsmed Stock Split?
Carlsmed has split 0 times. (See the CARL stock split history page for full effective split date and price information.)
How Many Employees Does Carlsmed Have?
Carlsmed has 127 employees.
What is the current trading status of Carlsmed (CARL)?
As of 21/04/2026, Carlsmed (CARL) is trading at a price of 10.75 USD, with a previous close of 10.94 USD. The stock has fluctuated within a day range of 10.73 USD to 11.27 USD, while its 52-week range spans from 8.50 USD to 17.19 USD.
What Is Carlsmed (CARL) Price Target According to Analysts?
The average 12-month price target for Carlsmed is 18.60 USD, with a high estimate of 23 USD and a low estimate of 17 USD. 5 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +73.02% Upside potential.
Industry Spotlight
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.